the Effect of Universal Salt Iodization on Thyroid Diseases

NCT ID: NCT01838629

Last Updated: 2013-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12438 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. acquire the environmental iodine status of Hangzhou
2. acquire the iodine status of population in Hangzhou
3. acquire the prevalence of thyroid diseases in Hangzhou
4. explore the association between iodized salt and thyroid disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Nodule

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

thyroid nodule

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age ≥ 6 years old;
2. living for above 5 years at present residence.

Exclusion Criteria

1. resident with coronary angiography (CAG) or endoscopic retrograde cholangiopancreatography (ERCP) in 6 months;
2. resident taking amiodarone drug;
3. resident with abnormal kidney function or serious illness
Minimum Eligible Age

6 Years

Maximum Eligible Age

86 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Weimin Xu

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Weimin Xu

Superintendent of Department of Endemic Diseases Control and Prevention,Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Weimin Xu

Role: PRINCIPAL_INVESTIGATOR

Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hangzhou Center of Disease Control and Prevention

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Xu W, Chen Z, Li N, Liu H, Huo L, Huang Y, Jin X, Deng J, Zhu S, Zhang S, Yu Y. Relationship of anthropometric measurements to thyroid nodules in a Chinese population. BMJ Open. 2015 Dec 21;5(12):e008452. doi: 10.1136/bmjopen-2015-008452.

Reference Type DERIVED
PMID: 26692553 (View on PubMed)

Chen Z, Xu W, Huang Y, Jin X, Deng J, Zhu S, Liu H, Zhang S, Yu Y. Associations of noniodized salt and thyroid nodule among the Chinese population: a large cross-sectional study. Am J Clin Nutr. 2013 Sep;98(3):684-92. doi: 10.3945/ajcn.112.054353. Epub 2013 Jul 10.

Reference Type DERIVED
PMID: 23842457 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20090833B27

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Iodine Supplementation in Obesity
NCT01985204 COMPLETED NA
Iodine Supplementation in Graves' Hyperthyroidism
NCT06540469 NOT_YET_RECRUITING NA